Literature DB >> 11867133

Overcoming restenosis with sirolimus: from alphabet soup to clinical reality.

Michael Poon1, Juan Jose Badimon, Valentin Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11867133     DOI： 10.1016/s0140-6736(02)07751-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

Authors:  Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 2.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

3.  Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model.

Authors:  B Scheller; A Grandt; S Wnendt; G Lorenz; M Böhm; G Nickenig
Journal:  Z Kardiol       Date:  2005-07

Review 4.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies.

Authors:  Qing Yu; Xudong Shi; Yu Feng; K Craig Kent; Lingjun Li
Journal:  Anal Chim Acta       Date:  2017-03-16       Impact factor: 6.558

6.  Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.

Authors:  A Heredia; A Amoroso; C Davis; N Le; E Reardon; J K Dominique; E Klingebiel; R C Gallo; R R Redfield
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-12       Impact factor: 11.205

7.  Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.

Authors:  Caroline Kinnear; Wing Y Chang; Shahryar Khattak; Aleksander Hinek; Tadeo Thompson; Deivid de Carvalho Rodrigues; Karen Kennedy; Naila Mahmut; Peter Pasceri; William L Stanford; James Ellis; Seema Mital
Journal:  Stem Cells Transl Med       Date:  2012-12-21       Impact factor: 6.940

8.  No major neurologic complications with sirolimus use in heart transplant recipients.

Authors:  Diederik van de Beek; Walter K Kremers; Sudhir S Kushwaha; Christopher G A McGregor; Eelco F M Wijdicks
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

9.  Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.

Authors:  Shengsi Zhu; Hema Viswambharan; Thusitha Gajanayake; Xiu-Fen Ming; Zhihong Yang
Journal:  BMC Cardiovasc Disord       Date:  2005-07-15       Impact factor: 2.298

Review 10.  The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?

Authors:  Fabrizio Montecucco; Sabine Steffens; François Mach
Journal:  Clin Dev Immunol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.